Where is FDNA located?

FDNA is headquartered in Herzliya, Israel.

Who is the current CEO of FDNA?

Erik A Feingold of FDNA. They have also founded 1 company.

How many employees does FDNA have?

As of Jul 31, 2026, the latest employee count at FDNA is 47.

Where does FDNA rank among its competitors?

FDNA ranks 66th amongst 1137 active competitors, of which 169 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of FDNA?

FDNA's top competitors include Strand Life Sciences, PathAI and Deciphex. Among them, Techcyte secured the most recent funding round in April, 2026.

FDNA - 2026 Company Profile, Team, Funding & Competitors

FDNA is a funded company based in Herzliya (Israel), founded in 2010 by Moti Shniberg, Erik A Feingold, Lior Wolf and Dekel Gelbman. It operates as a Developer of neurogenetic search and reference solution for the detection of facial dysmorphic features. The company has 1137 active competitors, including 169 funded and 113 that have exited. Its top competitors include companies like Strand Life Sciences, PathAI and Deciphex.

Company Details

Developer of neurogenetic search and reference solution for the detection of facial dysmorphic features. The Facial Dysmorphology Novel Analysis (FDNA) technology, has developed Face2Gene a neurogenetic search, and reference solution that facilitates detection of facial dysmorphic features. It aids in accelerating the research and investigation of genetic syndromes while leveraging the ever-increasing amounts of data in human genetics and dysmorphology.

Website: fdna.com
Social
Email ID: *****@fdna.com

Key Metrics

Founded Year

2010

Location

Herzliya, Israel

Stage

Funding Raised

Investors

Nacre Capital & 1 more

Ranked

66^th among 1137 active competitors

Employee Count

47 as on Jul 31, 2026

Similar Companies

PathAI & 732 more

View FDNA's full profile

FDNA is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
imaware™ Inc CIN: 82-5045579 , United States, Active	Dec 31, 2016	-	-	-
FDNA LTD CIN: 514619584 , Israel, Active	May 23, 2011	-	-	-

FDNA is a funded company. FDNA has 2 institutional investors.

View details of FDNA's funding rounds and investors

The founders of FDNA are Moti Shniberg, Erik A Feingold, Lior Wolf and Dekel Gelbman.

Here are the details of FDNA's key team members:

Moti Shniberg: Co-Founder & Chairman of FDNA and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Erik A Feingold: Co-Founder & CEO of FDNA and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Lior Wolf: Co-Founder of FDNA. They serve on the board of 1 company.
Dekel Gelbman: Former Founder of FDNA.
Contact Info: 1 email address

FDNA's Board of Directors

FDNA's board has 3 active members. Moti Shniberg, Erik A Feingold and Lior Wolf are part of team.

Here is the list of FDNA's board of directors:

Name	Type	Representing	Status	Duration
Moti Shniberg	Team	-	Current	-
Erik A Feingold	Team	-	Current	-
Lior Wolf	Team	-	Current	-

View details of FDNA's Founder profiles and Board Members

FDNA's employee count trend

FDNA has 47 employees as of Jul 26. Here is FDNA's employee count trend over the years:

Uncover FDNA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FDNA include Strand Life Sciences, PathAI and Deciphex. Here is the list of Top 10 competitors of FDNA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	71/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
5th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
6th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
7th	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	T. Rowe Price, ADIA & 22 others	63/100
8th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	62/100
9th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
10th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
66th	FDNA 2010, Herzliya (Israel), Funding Raised	Developer of neurogenetic search and reference solution for the detection of facial dysmorphic features	-	Nacre Capital, Clal Biotechnology Industries	44/100